HT

Hema Tripathi

Active Director Director DIN 09850455
DIN 09850455 First appointment Jan 2023 Primary industry Agriculture
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value •••• Premium profile

About Hema Tripathi

Data last updated:

Hema Tripathi is a Director at Cytolife Agritech Private Limited (since 2023). The company operates in Agriculture. Cytolife Agritech Private Limited reported revenue of ₹1.92 Cr (FY 2025).

DIN 09850455
Primary Designation Director
Industry Agriculture
First Appointment 05 Jan 2023
Oldest Company Age 3 yrs
Largest company Cytolife Agritech Private Limited · ₹1.92 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cytolife Agritech Private Limited U01100MH2023PTC396834
Director05 Jan 20232023₹1.92 Cr (FY 2025)Active

Board colleagues of Hema Tripathi

Directorship timeline

Open interactive timeline →
Cytolife Agritech Private Limited
Premium access

Shareholding and investment profile for Hema Tripathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hema Tripathi

Hema Tripathi currently holds 1 directorship: Cytolife Agritech Private Limited (Director, since 05 Jan 2023, revenue ₹1.92 Cr (FY 2025)).

Hema Tripathi was first appointed on 05 Jan 2023 as Director at Cytolife Agritech Private Limited.

The current boards of Hema Tripathi's companies include Amit Kumar Tripathi (Cytolife Agritech Private Limited), Vani Tiwari (Cytolife Agritech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available